Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

Robin L. Jones(Institute of Cancer Research), Ian E. Smith(Papworth Hospital), Alistair Ring(National Health Service), G. Walsh(Royal Marsden NHS Foundation Trust), Sunil R. Lakhani(Sullivan Nicolaides Pathology), S. Ashley(Royal Marsden NHS Foundation Trust)
British Journal of Cancer
January 17, 2006
10.1038/sj.bjc.6602950
Cited by 114

Related Papers

Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The landscape of cancer genes and mutational processes in breast cancer
|Nature|2012|1.7k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978